Zfra treatment reduced the percentage of apoptotic nuclei in the hippocampus and specifically suppressed WWOX phosphorylation at Ser14, which is a form of WWOX they associated with AD progression and severity [202]. Here, WWOX is linked to Alzheimer disease.